We determined the prevalence of metabolic syndrome (MS) in Okinawa from crosssectional results of an annual physical chekup. We also calculated the homeostasis model assessment ratio (HOMA-R) as an index of insulin resistance, and examined the relationship between HOMA-R and MS. We studied 3,839 men (mean age 49. 
Introduction
Okinawa has the highest population of centenarians in the world. The proclamation of a World Longevity Region was advocated in 1995. On the other hand, the European and American lifestyle with its high-fat diet has been widely adopted by the younger generations, and caused the highest obesity rate in Japan. This trend is particularly marked among men -half of men aged over 40 years are obese (body mass index (BMI) ≥ 25) (1) . We determined the prevalence of metabolic syndrome (MS) from cross-sectional results of an annual physical chekup conducted in our hospital in order to clarify the present status of MS in Okinawa. We also determined the homeostasis model assessment ratio (HOMA-R) as an index of insulin resistance (2) to examine the relationship between HOMA-R and MS.
Subjects and Methods
The subjects who consented to participate were 3,839 men and 3,146 women, a total of 6,985 people aged from 30 to 79 years. We recruited the participants from among individuals taking an annual physical checkup of our hospital between May 2003 and March 2004. The participants, local resident in most cases, visited us at their own choice, and therefore, the sampling was not randomized. However, there were no difference in lifestyle, anthropometry, and characteristics between the participants and 36,946 Okinawan residents in The 2002 report of Basic health examination, surveyed by the Okinawan prefectural government. We didn't exclude any medicated cases. Based on the MS diagnostic criteria according to the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III: ATP III) (3), we identified the following 5 risk factors: hypertriglyceridemia (triglycerides ≥ 150 mg/dl), low high-density lipoprotein (HDL) cholesterol (HDL cholesterol < 40 mg/dl for men and < 50 mg/dl for women), hypertension (systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85 mmHg), and impaired fasting glucose (fasting blood glucose ≥ 110 mg/dl). Allowing for the difference in physical stature between Japanese and American people, we defined men with an abdominal circumference of ≥ 85 cm and women with ≥ 90 cm as being abdominally obese, based on the diagnostic criteria for visceral fat-type obesity of the Japan Society for the Study of Obesity (4) . Those who met 3 or more of the 5 risk factors listed above were diagnosed as having MS. The abdominal circumference was measured at the level of the umbilicus in a standing and fasting condition. Blood pressure was measured using an Automatic BP Monitor (BP-203RV2, COLIN Corporation). The triglyceride level was determined by the enzymatic colorimetric method (Cholestest TG), HDL cholesterol level by a direct method (Cholestest N HDL), blood glucose level by the glucose dehydrogenase method (Gluc-DH), and insulin level by the chemoluminescence enzymatic immunoassay method (CLEIA). As an index of insulin resistance, HOMA-R was calculated using the formula: fasting insulin level (µU/ml) × fasting glucose level (mg/dl)/405. The Statistical Package for Social Science (SPSS) Ver. 11.5.1J for Windows was used for statistical analysis. Results are presented as the mean ± standard deviation. The difference between two groups was determined using Student's unpaired t test, the frequency between two groups was compared using the chi-square test, and the correlation between the number of risk factors and HOMA-R was determined using Spearman's rank correlation test. The level of significance was set at p < 0.05. This research was planned and implemented with the approval of the Hospital Ethics Committee.
Results
The mean age of the subjects was 49.2 years for men and 50.0 years for women. The mean BMI, abdominal circumference, triglyceride level, blood pressure, fasting glucose level, and HOMA-R were significantly higher among men, and the HDL cholesterol level was signifi- cantly lower among men (Table 1) . For the 5 ATP III risk factors, all positive rates were significantly higher among men, except for a low HDL cholesterol level (Fig. 1) . The prevalence of MS was 22.5% for men and 2.8% for women in their 30s, 29.7% for men and 6.7% for women in their 40s, 33.4% for men and 13.2% for women in their 50s, 33.9% for men and 17.8% for women in their 60s, and 34.0% for men and 20.5% for women in their 70s. The unadjusted prevalence of MS was 30.2% for men and 10.3% for women; it was significantly higher among men (Fig. 2) . While 71.7% of men and 53.9% of women with impaired fasting glucose had MS, 5.4% of men and 3.9% of women without abdominal obesity were diagnosed as having MS (Fig. 3) . The mean HOMA-R was 1.6 for men and 1.6 for women among people with no risk factors, 2.0 for men and 2.1 for women (a significant difference) with one risk factor, 2.7 for men and 2.7 for women with two risk factors, 3.6 for men and 4.0 for women (a significant difference) with three risk factors, 4.9 for men and 5.2 for women with four risk factors, 5.8 for men and 5.9 for women with five risk factors, respectively. According to the increase in the number of risk factors, both men and women displayed significant increases in insulin resistance (Fig. 4) . Basal characteristics of the people with HOMA-R ≥ 3.0 aged under 50 and aged 50 and over by sex are listed in Table 2a and 2b, respectively. The percentage of people with HOMA-R ≥ 3.0 who were diagnosed as having MS was 55.9% for men aged under 50 years, and 59.9% for men aged 50 years and over (no significant difference), whereas it was 27.1% for women aged under 50 years, and 43.3% for women aged 50 years and over (a significant difference) (Fig. 5) . Logistic regression analysis with the presence or absence of MS as a dependent variable, and sex, age, and HOMA-R as independent variables, gave significant odd ratios of 3.6 for men versus women, 1.4 for a 10-year age increment, and 2.0 for an elevation of HOMA-R above 1.0 (Table 3) .
Discussion
Although the criteria for abdominal obesity vary, Ford et al. (5) have reported that MS was found in 24.0% of men and 23.4% of women in the US. Takeuchi et al. (6) investigated Japanese men using the same criteria that we used, and reported a 24.4% prevalence of MS. Compared with these results, the present study showed a much higher prevalence of MS among men, and a much lower prevalence among women.
For the 5 risk factors, the highest rate of abdominal obesity was found among men, followed by hypertension, hypertriglyceridemia, impaired fasting glucose, and low HDL cholesterol, in that order. This does not contradict the hypothesis that visceral fat-type obesity may be the leading factor in MS, and glucose tolerance compensated by hyperinsulinemia may be sustained until a late phase. The rate of abdominal obesity was lower than that of low HDL cholesterol among women, which suggests that we may need to define the abdominal obesity criteria separately from the diagnostic criteria for visceral fat-type obesity for the diagnosis of MS among women in Japan. HOMA-R, an index of insulin resistance, correlated with the number of MS risk factors among both men and women. Among women aged 50 and over, nearly half those with at least moderate insulin resistance were found to have MS, but fewer than 30% of women aged under 50 years were found to have MS. A similar phenomenon was not found among men. This suggests that "insulin resistance resistance" may be present among pre-menopausal women.
Ford et al. reported that the prevalence of MS in the US increased with age among both men and women. We found the same trend among women in Okinawa. By contrast, a high prevalence of MS was found in all age groups among men in Okinawa, including the younger generation. A European or American lifestyle tends to be more widely adopted by younger generations, and this may have cancelled out the influence of aging. As a result, the odds ratio of the elevation of HOMA-R above 1.0 was higher than that for a 10-year age increment. This means that, in Japanese, MS should be identified as a lifestyle-related disease rather than an age-related disease.
Considering the increased risk of ischemic heart disease in multiple metabolic disorders in Japanese (7, 8) , the fact that one out of three men in Okinawa has MS makes us deeply concerned about the life expectancy of the younger generation. MS will increasingly become a major public health concern not only in Okinawa but also all over Japan in the near future. 
